Clinical trial
Antiretroviral Therapy for Advanced HIV Disease in South Africa
NCT00342355 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00342355 |
|---|---|
| Title | Antiretroviral Therapy for Advanced HIV Disease in South Africa |
| Official title | Randomized, Open-Label 2x2 Factorial Study to Compare the Safety and Efficacy of Different Combination Antiretroviral Therapy Regimens in Treatment Naive Patients With Advanced HIV Disease and/or CD4+ Cell Counts Less Than 200 Cells/MicroL |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Drug |
| Interventions | Zidovudine, Stavudine, Didanosine, Lamivudine, Efavirenz, Lopinavir/Ritonavir |
| Enrollment | 1,771 |
| Start date | Jan 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jun 21, 2006 |
| Last update posted | May 21, 2013 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: